Rockefeller Capital Management
TIL icon

Rockefeller Capital Management’s Instil Bio TIL Stock Holding History

Rockefeller Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,730
Closed -$49K – 2017
2023
Q1 		$49K Sell
3,730
-85
-2% -$1.26K ﹤0.01% 1926
2022
Q4 		$48K Buy
3,815
+2,259
+145% +$112K ﹤0.01% 2414
2022
Q3 		$150K Buy
1,556
+641
+70% +$73.3K ﹤0.01% 1783
2022
Q2 		$83K Buy
915
+830
+976% +$118K ﹤0.01% 2044
2022
Q1 		$18K Hold
85
– – ﹤0.01% 2773
2021
Q4 		$29K Hold
85
– – ﹤0.01% 2463
2021
Q3 		$30K Hold
85
– – ﹤0.01% 2401
2021
Q2 		$32K Buy
+85
New +$31.5K ﹤0.01% 2274

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rockefeller Capital Management's TIL Position: Q2 2023 in Review

Rockefeller Capital Management sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 3,730 shares — an estimated $49K sold.

Rockefeller Capital Management first reported a position in TIL in Q2 2021 and held it in 8 quarters. The position peaked at $150K in Q3 2022. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • Rockefeller Capital Management reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 3,730 Instil Bio shares in Q2 2023, an estimated $49K.
  • Rockefeller Capital Management first reported a position in Instil Bio in Q2 2021 and held it in 8 quarters.
  • Rockefeller Capital Management's Instil Bio position peaked at $150K in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Rockefeller Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.